Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Company Description (as filed with the SEC)
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina and a line of advanced biological tissue products called Peripatch(TM) ("Peripatch") that are used as key components in third-party medical products including transcatheter heart valves. In 2009, Neovasc started initial activities to develop novel technologies for catheter-based treatment of mitral valve disease. Based on the early positive results of these activities, the Company formally launched a program to develop the Tiara technology. Neovasc established a separate entity, Neovasc Tiara Inc. ... More ...
Where does NVCN fit in the risk graph?
|Annual EPS Est:||$-0.29|
|Quarterly EPS Est:||-0.05|